Joseph M. Giaconia

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

S. Schwartz, M. Resnick, T. P. Pretlow, 1996, Cancer research.

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

S. Schwartz, M. Resnick, T. P. Pretlow, 1994, Cancer research.

A new human prostate carcinoma cell line, 22Rv1

S. Schwartz, T. P. Pretlow, J. Rhim, 1999, In Vitro Cellular & Developmental Biology - Animal.

Prostate cancer and other xenografts from cells in peripheral blood of patients.

S. Schwartz, C. Connell, M. Resnick, 2000, Cancer research.

Xenografts of primary human prostatic carcinoma.

M. Resnick, T. P. Pretlow, E. Kursh, 1993, Journal of the National Cancer Institute.